Overview

Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Intranasal Ketorolac tromethamine has a potential role as a short term pain management tool for Interstitial Cystitis without the risk and undesirable effects of narcotics.
Phase:
Phase 4
Details
Lead Sponsor:
Citrus Valley Medical Research, Inc.
Treatments:
Ketorolac
Ketorolac Tromethamine